Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Yizhao Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9749-5227; OpenAlex author ID A5101605172. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers

Papers 7

  1. Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5. Co-author DOI 10.1038/s12276-024-01346-4↗
  2. Author Correction: Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL… Co-author DOI 10.1038/s12276-024-01363-3↗
  3. Exosomes Derived from Pancreatic Cancer Cells Induce Osteoclast Differentiation Through the miR125a-5p/TNFRSF1B Pathway. Co-author DOI 10.2147/ott.s282319↗
  4. FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors. Co-author DOI 10.18632/aging.102564↗
  5. Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer. First author DOI 10.7150/jca.27590↗
  6. Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.01.026↗
  7. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Co-author DOI 10.1016/j.canlet.2018.05.027↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yulian Wu · 7 shared papers, 2018–2024 · strength 0.81
  2. Yongji Sun · 2 shared papers, 2024 · strength 0.34
  3. Zengyu Feng · 2 shared papers, 2024 · strength 0.34
  4. Hongxia Xu · 2 shared papers, 2024 · strength 0.34
  5. Qiaojun He · 2 shared papers, 2024 · strength 0.34
  6. Xiawei Li · 2 shared papers, 2024 · strength 0.34
  7. Jiali Gong · 2 shared papers, 2024 · strength 0.34
  8. Pengping Li · 4 shared papers, 2018–2020 · strength 0.33
  9. Yi Zhu · 2 shared papers, 2020–2021 · strength 0.24
  10. Muxing Kang · 3 shared papers, 2018–2019 · strength 0.23
  11. Yuefeng Zhang · 2 shared papers, 2018–2020 · strength 0.18
  12. Lantian Wang · 2 shared papers, 2018 · strength 0.14
  13. Yiqun Fan · 1 shared paper, 2021 · strength 0.13
  14. Maoming Xiong · 1 shared paper, 2020 · strength 0.10
  15. Yue‐Feng Zhang · 1 shared paper, 2019 · strength 0.09
  16. Xiaoman He · 1 shared paper, 2019 · strength 0.09
  17. Bin Juan Yang · 1 shared paper, 2018 · strength 0.07
  18. Wenjie Lu · 1 shared paper, 2018 · strength 0.07
  19. Qing Chen · 1 shared paper, 2018 · strength 0.07
  20. Qingqu Guo · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.